Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-30 @ 10:38 AM
Study NCT ID:
NCT04659733
Status:
UNKNOWN
Last Update Posted:
2020-12-09
First Post:
2020-12-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children
Sponsor:
Yizhuo Zhang
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-12-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-02
First Submit QC Date:
None
Study First Post Date:
2020-12-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-08
Last Update Post Date:
2020-12-09
Last Update Post Date Type:
ACTUAL